Major strategies for antiviral therapies involve either antibodies which neutralize virus particles, or drugs which target cellular proteins and disrupt the virus life cycle. Protein-protein interactions are involved in each step of the virus cycle, from the viral attachment to the host cell through to its replication.
Homogeneous assays like AlphaLISA™, TR-FRET, or HTRF™ are good research tools for testing new protein-protein interaction inhibitors. In this literature review, we have compiled the latest publications about homogeneous assays.
Featured in this review:
Literature review on protein-protein interaction assays for virology research